Skip to content

Safety of Magnetic Resonance Imaging in Non-MRI Conditional Pacemakers and ICD Devices

Safety of Magnetic Resonance Imaging in Non-MRI Conditional Pacemakers and ICD Devices

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02906189
Enrollment
1500
Registered
2016-09-20
Start date
2016-09-30
Completion date
2021-09-30
Last updated
2016-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac

Brief summary

The primary objective of the study is to determine the safety of MRI in patients with non-MRI conditional pacemakers. The secondary objective is to determine if there are clinically relevant parameter changes in the devices.

Interventions

RADIATIONMRI

Sponsors

Banner Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

. All patients with non-MRI conditional pacemakers and ICDs between the ages of 18-85 will be eligible to participate. Medical records will be reviewed to confirm the date and make/model of device implanted. Ordering physician discusses the MRI request with radiologist, documenting that there is no appropriate alternate imaging test. Patient must have an appointment with a cardiologist/electrophysiologist prior to MRI. Banner Health policy for standard of care guidelines involving patients receiving MRI's will be followed.

Exclusion criteria

. Patients will be excluded from MRI based on the Department of Radiology protocol. Additional

Design outcomes

Primary

MeasureTime frame
Death during the MRI scanImmediate

Secondary

MeasureTime frame
Loss of pacemaker capture during MRIImmediate
Electrical reset of the deviceImmediate
Decrease in battery voltage >0.04v6 months
Change in pacing lead impedance ≥ 50 Ω6 months
Change in high-voltage lead impedance ≥ 3 Ω6 months
New onset atrial or ventricular arrhythmia during MRIImmediate
Decrease in P wave measurement ≥ 50%6 months
Decrease in R wave measurement ≥ 25%6 months
Generator failure requiring immediate replacementImmediate
Lead failure requiring immediate replacementImmediate
Increase in pacing threshold ≥ 0.50 V @ 0.4 ms6 months

Countries

United States

Contacts

Primary ContactMichael Morris, MD
michael.morris@bannerhealth.com602-839-4850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026